vs
Adagio Medical Holdings, Inc.（ADGM）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc自由现金流更多（$68.0M vs $-3.5M）
Adagio Medical Holdings, Inc.是一家医疗科技企业，专注于开发和商业化用于治疗包括房颤在内的各类心律失常病症的冷冻消融平台，产品面向电生理临床医师，核心市场覆盖北美及欧洲，致力于提升心律疾病患者的治疗安全性与效果。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
ADGM vs PEN — 直观对比
营收规模更大
PEN
是对方的Infinity倍
$0
自由现金流更多
PEN
多$71.6M
$-3.5M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $0 | $385.4M |
| 净利润 | $-10.1M | $47.3M |
| 毛利率 | — | 68.0% |
| 营业利润率 | — | 15.4% |
| 净利率 | — | 12.3% |
| 营收同比 | — | 22.1% |
| 净利润同比 | -380.6% | 40.6% |
| 每股收益（稀释后） | $-0.66 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADGMPEN
| Q4 25 | — | $385.4M | ||
| Q3 25 | $0 | $354.7M | ||
| Q2 25 | — | $339.5M | ||
| Q1 25 | — | $324.1M | ||
| Q4 24 | — | $315.5M | ||
| Q3 24 | $132.0K | $301.0M | ||
| Q2 24 | $254.0K | $299.4M | ||
| Q1 24 | — | $278.7M |
净利润ADGMPEN
| Q4 25 | — | $47.3M | ||
| Q3 25 | $-10.1M | $45.9M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | $3.6M | $29.5M | ||
| Q2 24 | $-5.7M | $-60.2M | ||
| Q1 24 | — | $11.0M |
毛利率ADGMPEN
| Q4 25 | — | 68.0% | ||
| Q3 25 | — | 67.8% | ||
| Q2 25 | — | 66.0% | ||
| Q1 25 | — | 66.6% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | -213.6% | 66.5% | ||
| Q2 24 | -168.5% | 54.4% | ||
| Q1 24 | — | 65.0% |
营业利润率ADGMPEN
| Q4 25 | — | 15.4% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.0% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | -3352.3% | 11.7% | ||
| Q2 24 | -2621.7% | -27.0% | ||
| Q1 24 | — | 4.3% |
净利率ADGMPEN
| Q4 25 | — | 12.3% | ||
| Q3 25 | — | 12.9% | ||
| Q2 25 | — | 13.3% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | 2731.8% | 9.8% | ||
| Q2 24 | -2257.5% | -20.1% | ||
| Q1 24 | — | 3.9% |
每股收益（稀释后）ADGMPEN
| Q4 25 | — | $1.20 | ||
| Q3 25 | $-0.66 | $1.17 | ||
| Q2 25 | — | $1.15 | ||
| Q1 25 | — | $1.00 | ||
| Q4 24 | — | $0.88 | ||
| Q3 24 | $0.02 | $0.75 | ||
| Q2 24 | $-7.35 | $-1.55 | ||
| Q1 24 | — | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.7M | $186.9M |
| 总债务越低越好 | $21.2M | — |
| 股东权益账面价值 | $-1.3M | $1.4B |
| 总资产 | $31.5M | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ADGMPEN
| Q4 25 | — | $186.9M | ||
| Q3 25 | $4.7M | $321.0M | ||
| Q2 25 | — | $421.8M | ||
| Q1 25 | — | $376.1M | ||
| Q4 24 | — | $324.4M | ||
| Q3 24 | $28.3M | $280.5M | ||
| Q2 24 | — | $288.3M | ||
| Q1 24 | — | $223.1M |
总债务ADGMPEN
| Q4 25 | — | — | ||
| Q3 25 | $21.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADGMPEN
| Q4 25 | — | $1.4B | ||
| Q3 25 | $-1.3M | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $76.6M | $1.1B | ||
| Q2 24 | $-140.5M | $1.2B | ||
| Q1 24 | — | $1.2B |
总资产ADGMPEN
| Q4 25 | — | $1.8B | ||
| Q3 25 | $31.5M | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $107.2M | $1.5B | ||
| Q2 24 | $-140.5M | $1.5B | ||
| Q1 24 | — | $1.6B |
负债/权益比ADGMPEN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $-3.5M | $68.0M |
| 自由现金流率自由现金流/营收 | — | 17.7% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.83× |
| 过去12个月自由现金流最近4个季度 | — | $174.9M |
8季度趋势，按日历期对齐
经营现金流ADGMPEN
| Q4 25 | — | $86.5M | ||
| Q3 25 | $-3.0M | $58.3M | ||
| Q2 25 | — | $44.9M | ||
| Q1 25 | — | $49.0M | ||
| Q4 24 | — | $51.1M | ||
| Q3 24 | $-6.4M | $56.5M | ||
| Q2 24 | — | $22.6M | ||
| Q1 24 | — | $38.3M |
自由现金流ADGMPEN
| Q4 25 | — | $68.0M | ||
| Q3 25 | $-3.5M | $42.0M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.5M | ||
| Q4 24 | — | $45.7M | ||
| Q3 24 | $-6.9M | $51.0M | ||
| Q2 24 | — | $18.1M | ||
| Q1 24 | — | $32.5M |
自由现金流率ADGMPEN
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | 11.8% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | -5254.5% | 16.9% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 11.7% |
资本支出强度ADGMPEN
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | 437.9% | 1.8% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 2.1% |
现金转化率ADGMPEN
| Q4 25 | — | 1.83× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | -1.76× | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
